Elite Pharmaceuticals (ELTP) Cash from Financing Activities (2010 - 2026)
Elite Pharmaceuticals' Cash from Financing Activities came in at -$114,594 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$4.13 million a year earlier.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Elite Pharmaceuticals reported Cash from Financing Activities of -$306,219; for FY2026 (ended Mar 31, 2026), it was -$4.32 million.
- Going back by fiscal year, Cash from Financing Activities was -$825,740 in FY2025, $3.34 million in FY2024 (+96.2%), $1.7 million in FY2023 and -$667,133 in FY2022.
- The five-year range for quarterly Cash from Financing Activities is -$12.5 million (fiscal Q4 2023) to $11.9 million (fiscal Q1 2023).
- Business Quant data shows ELTP's Cash from Financing Activities at -$41,522 (Q4 2026), -$33,635 (Q3 2026) and -$116,468 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | -114,594.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -114,594.00 |
| Mar 31, 2026 | -41,522.00 |
| Dec 31, 2025 | -33,635.00 |
| Sep 30, 2025 | -116,468.00 |
| Jun 30, 2025 | -4.13 Mn |
| Mar 31, 2025 | -137,044.00 |
| Dec 31, 2024 | -193,104.00 |
| Sep 30, 2024 | -320,686.00 |
| Jun 30, 2024 | -174,906.00 |
| Mar 31, 2024 | -400,969.00 |
| Dec 31, 2023 | -37,575.00 |
| Sep 30, 2023 | -179,498.00 |
| Jun 30, 2023 | 3.96 Mn |
| Mar 31, 2023 | -12.50 Mn |
| Dec 31, 2022 | -77,369.00 |
| Sep 30, 2022 | 2.39 Mn |
| Jun 30, 2022 | 11.90 Mn |
| Mar 31, 2022 | -94,244.00 |
| Dec 31, 2021 | -153,864.00 |
| Sep 30, 2021 | -266,476.00 |
API Access
Elite Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();